ES545859A0 - Un procedimiento para la preparacion de una trans-octahidro-oxazolo(4,5-g)quinolina - Google Patents

Un procedimiento para la preparacion de una trans-octahidro-oxazolo(4,5-g)quinolina

Info

Publication number
ES545859A0
ES545859A0 ES545859A ES545859A ES545859A0 ES 545859 A0 ES545859 A0 ES 545859A0 ES 545859 A ES545859 A ES 545859A ES 545859 A ES545859 A ES 545859A ES 545859 A0 ES545859 A0 ES 545859A0
Authority
ES
Spain
Prior art keywords
octahidro
oxazolo
quinoline
trans
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES545859A
Other languages
English (en)
Other versions
ES8704499A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES545859A0 publication Critical patent/ES545859A0/es
Publication of ES8704499A1 publication Critical patent/ES8704499A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES545859A 1984-08-02 1985-08-02 Un procedimiento para la preparacion de una trans-octahidro-oxazolo(4,5-g)quinolina Expired ES8704499A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63723284A 1984-08-02 1984-08-02

Publications (2)

Publication Number Publication Date
ES545859A0 true ES545859A0 (es) 1987-04-01
ES8704499A1 ES8704499A1 (es) 1987-04-01

Family

ID=24555086

Family Applications (2)

Application Number Title Priority Date Filing Date
ES545859A Expired ES8704499A1 (es) 1984-08-02 1985-08-02 Un procedimiento para la preparacion de una trans-octahidro-oxazolo(4,5-g)quinolina
ES551964A Expired ES8800231A1 (es) 1984-08-02 1986-02-13 Un procedimiento para la preparacion de una trans-octahidro-oxazolo 4,5-g quinolina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES551964A Expired ES8800231A1 (es) 1984-08-02 1986-02-13 Un procedimiento para la preparacion de una trans-octahidro-oxazolo 4,5-g quinolina

Country Status (19)

Country Link
EP (1) EP0172697B1 (es)
JP (1) JPH0670063B2 (es)
KR (1) KR880001430B1 (es)
AR (1) AR240822A1 (es)
AT (1) ATE67766T1 (es)
AU (1) AU569406B2 (es)
CA (1) CA1292742C (es)
DE (1) DE3584205D1 (es)
DK (1) DK349185A (es)
ES (2) ES8704499A1 (es)
GR (1) GR851895B (es)
HU (1) HU193338B (es)
IE (1) IE58695B1 (es)
IL (1) IL75991A0 (es)
NZ (1) NZ212946A (es)
PH (1) PH22541A (es)
PT (1) PT80899B (es)
SU (1) SU1421258A3 (es)
ZA (1) ZA855830B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents
US4939259A (en) * 1989-07-24 1990-07-03 Eli Lilly And Company 2-oxo-pyrido[2,3-g]quinoline derivatives
US6395744B1 (en) 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
JP2002518435A (ja) * 1998-06-22 2002-06-25 クイーンズ ユニバーシティ アット キングストン 女性の性機能不全の治療または改善のための方法および組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
NZ212947A (en) * 1984-08-03 1988-07-28 Lilly Co Eli Preparation of tricyclic quinoline derivatives
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines

Also Published As

Publication number Publication date
EP0172697B1 (en) 1991-09-25
AR240822A1 (es) 1991-02-28
NZ212946A (en) 1988-07-28
IE58695B1 (en) 1993-11-03
AR240822A2 (es) 1991-02-28
IE851921L (en) 1986-02-02
KR880001430B1 (ko) 1988-08-08
ES551964A0 (es) 1987-10-16
AU569406B2 (en) 1988-01-28
JPS6147487A (ja) 1986-03-07
ZA855830B (en) 1987-03-25
IL75991A0 (en) 1985-12-31
DK349185D0 (da) 1985-08-01
ES8800231A1 (es) 1987-10-16
HUT38348A (en) 1986-05-28
CA1292742C (en) 1991-12-03
GR851895B (es) 1985-12-03
DK349185A (da) 1986-02-03
DE3584205D1 (de) 1991-10-31
HU193338B (en) 1987-09-28
ES8704499A1 (es) 1987-04-01
EP0172697A3 (en) 1986-03-12
EP0172697A2 (en) 1986-02-26
PT80899B (pt) 1987-12-30
PH22541A (en) 1988-10-17
KR860001815A (ko) 1986-03-22
PT80899A (en) 1985-09-01
AU4573785A (en) 1986-02-06
SU1421258A3 (ru) 1988-08-30
ATE67766T1 (de) 1991-10-15
JPH0670063B2 (ja) 1994-09-07

Similar Documents

Publication Publication Date Title
ES545464A0 (es) Un procedimiento para la preparacion de tetrahidroftalimidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES541200A0 (es) Un procedimiento para la preparacion de un derivado de dibenzoilmetano.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES548073A0 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
ES556895A0 (es) Un procedimiento para la preparacion de l,2,4-triazoles
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES544521A0 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES546872A0 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES542120A0 (es) Un procedimiento para la preparacion de 1,4-dihidropiridinas.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES543997A0 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina.
ES557144A0 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihidroorotil-histidil-prolinamida
ES539592A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,4-dihidropiridina.
ES545859A0 (es) Un procedimiento para la preparacion de una trans-octahidro-oxazolo(4,5-g)quinolina
ES542882A0 (es) Un procedimiento para la preparacion de nuevas sulfonilureas.
ES545439A0 (es) Un procedimiento para la preparacion de 2-bencil-4-(4-piridil)-tiazoles.
ES522573A0 (es) Un procedimiento para la preparacion de dihidropiridinas.
ES548049A0 (es) Un procedimiento para la preparacion de nuevos derivados de dihidroisoquinolina.
ES541450A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas.
ES556896A0 (es) Un procedimiento para la preparacion de oxetanonas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612